ALLOGENIC BONE MARROW TRANSPLANTATION THERAPY

This adverse event was reported 54 times

These drugs are most commonly taken by patients reporting ALLOGENIC BONE MARROW TRANSPLANTATION THERAPY:

# Drug Count
0 METHOTREXATE 9
1 METHOTREXATE SODIUM 9
2 CYCLOPHOSPHAMIDE 7
3 CYCLOPHOSPHAMIDE FOR INJECTION 7
4 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 7
5 IMATINIB MESYLATE 7
6 CYCLOSPORINE 6
7 DASATINIB 6
8 CYTARABINE 5
9 ECULIZUMAB 4
See all common drugs associated with ALLOGENIC BONE MARROW TRANSPLANTATION THERAPY

ALLOGENIC BONE MARROW TRANSPLANTATION THERAPY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 OLUTASIDENIB 1 0.0035
1 DASATINIB 6 0.0006
2 MITOXANTRONE HYDROCHLORIDE 4 0.0006
3 GEMTUZUMAB OZOGAMICIN 2 0.0005
4 THIOGUANINE 1 0.0005
5 DEFEROXAMINE MESYLATE 1 0.0005
6 CLOFARABINE 1 0.0004
7 IMATINIB MESYLATE 7 0.0003
8 IDURSULFASE 1 0.0003
9 VANCOMYCIN HYDROCHLORIDE 2 0.0002
See all drugs enriched for association with ALLOGENIC BONE MARROW TRANSPLANTATION THERAPY